Hello readers. It's been awhile. I'm pleased to be working with Reuters on some events including this upcoming webinar on how to utilize RWD in cell and gene therapies with speakers from Novartis, BMS and Salesforce. Click here for more info.
The requirements of complex and delicate value chains within cell and gene therapies (CGT) is something pharma has traditionally never seen before. Leaders in CGT are innovating data sharing approaches by utilizing RWE and RWD across the value chain, and achieving multi-stakeholder alignment, to ensure commercial success.
Join C> delivery
trailblazers BMS, Novartis and Salesforce to learn how to turn data in
to true insights: that enhance the science, reduce the cost of deliver, improve
commercial decision-making and elevate the patient experience.
Sign up for the webinar “Cell and gene data innovation
and multi-stakeholder data transfer” here.
When you join, you will learn
how to:
•
Reimagine the
technology: digitally transform existing data integration models for cell and
gene therapies
•
Reach for the future
together: develop a multi-stakeholder strategy collaboratively, that aligns on
needs and capabilities
•
Cross-capture and
utilize data flow from R&D through to launch to win the marketplace with
science and data
•
Prepare for and
address the major barriers to success: such as infrastructure non-readiness,
digitally siloed stakeholders, underdeveloped partnerships, and data illiteracy
•
Turn data in to true
insights: that enhance the science, reduce the cost of deliver, improve
commercial decision making and elevate the patient experience
Please also feel free to
share with your colleagues working in C&G therapy, so they can benefit
too.
Lee
